Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-30

Clinical Trial Update: Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension [NA]

View source ↗

Summary

Completed trial comparing 0.9% normal saline versus 5% albumin for fluid resuscitation in cirrhosis with septic shock, reporting outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin 5% solution for IV use (human serum albumin)
  • Normal saline (0.9% sodium chloride) for IV use (sodium chloride 0.9% solution)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Cirrhosis With Septic Shock | NA | Status: COMPLETED